Skip to content

Welcome to Discover Pharma! Today is : October 11, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

Decentralized Trials

  • Clinical & Regulatory,Digital & Data,Opinion & Events

    Nine ladies dancing: uMotif – patient-centric trials and AI take centre stage in 2026

    As part of Discover Pharma’s 12 days of Christmas series, [...]

    May 5, 2026
  • Clinical & Regulatory,Drug Discovery & Development,Opinion & Events,Therapeutic Areas

    START launches Hope Hub to improve access to early-phase cancer trials

    START unveils the Hope Hub, a digital platform connecting patients, [...]

    May 5, 2026
  • Biotech & Pharma Business,Clinical & Regulatory,Drug Discovery & Development,Uncategorised

    Veeva unveils bold vision for simplifying, standardising, and AI-powered innovation

    In a keynote address that signaled both reflection and momentum, [...]

    May 5, 2026
  • Advanced Therapies,Clinical & Regulatory,Opinion & Events

    Digital shift aims to fix long-term gaps in cell and gene therapy trials

    Medable unveils a patient-first remote model to support 15-year safety [...]

    May 5, 2026
  • Clinical & Regulatory,Opinion & Events

    Flexibility and precision: How Phastar is driving innovation in clinical trials

    As the pharmaceutical industry marks World Clinical Trials Day 2025, [...]

    May 5, 2026
  • Clinical & Regulatory,Drug Discovery & Development,Opinion & Events

    Fixing the gender gap in clinical trials

    Dr Anita Phung, GP and medical monitor at Lindus Health, [...]

    May 5, 2026
  • Opinion & Events

    Global patient access gets boost with myTomorrows and Scout Clinical collaboration

    May 5, 2026

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • Novadip secures €10.4M to advance pivotal Phase 3 trial
    Categories: Advanced Therapies, Biotech & Pharma Business, Clinical & Regulatory, Research & Development, Therapeutic Areas
  • Telix to acquire ITM in $1.65BN radiopharmaceutical deal
    Categories: Biotech & Pharma Business, Manufacturing & Supply Chain, Pharmaceuticals and therapeutics, Research & Development, Therapeutic Areas
  • Andelyn to manufacture FDA-approved Fayuvi gene therapy for Sanfilippo syndrome
    Categories: Advanced Therapies, Biotech & Pharma Business, Central Nervous System, Clinical & Regulatory, Manufacturing & Supply Chain, Pharmaceuticals and therapeutics, Research & Development, Therapeutic Areas
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details.
OK
Go to Top